CSIMarket Company Name, Ticker, Customers, else..
 
Serina Therapeutics Inc   (NYSE: SER)
 
Price: $2.7300 $0.04 1.487%
Day's High: $2.740000009536743 Week Perf: 12.81 %
Day's Low: $ 2.51 30 Day Perf: 16.17 %
Volume (M): 14,840 52 Wk High: $ 5.83
Volume (M$): $ 0 52 Wk Avg: $2.81
Open: $2.70 52 Wk Low: $1.22



 Market Capitalization (Millions $) 45
 Shares Outstanding (Millions) 16
 Employees 16
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is a clinical-stage biotechnology firm developing drug candidates using its proprietary POZ drug delivery technology, which modifies drugs to enhance efficacy and safety. Its primary focus is on neurological diseases, particularly Parkinson's disease, with lead candidates such as SER 252 designed for continuous drug delivery via subcutaneous injection. The company also seeks to expand applications of the POZ technology through partnerships and licensing, including in RNA-based therapeutics and antibody drug conjugates.


   Company Address: 601 Genome Way Huntsville 35806 AL
   Company Phone Number: 327-9630   Stock Exchange / Ticker: NYSE SER


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DERM        5.22% 
JNJ        2.68% 
MRK        1.33% 
OGN        0.15% 
OPK        10.81% 
PFE        1.75% 
• View Complete Report
   



Stocks on the Move

Bucking the Trend Serina Therapeutics Inc Faces Challenges Amidst Insider Trading and Market Volatility, Yet Holds Promising Future Potential

Published Tue, Jul 9 2024 3:15 PM UTC

Word Count: 685The under-performance of Serina Therapeutics Inc shares this week can be attributed to a series of events that have impacted the company s stock performance. Despite recent market volatility and insider trading activities, there are lingering opportunities for the biotech company to rebound in the future.One significant event that affected Serina Therapeutics ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 2.39
PEG (TTM) -

Financial Strength Current
Quick Ratio 6.12
Working Capital Ratio 6.12
Leverage Ratio (MRQ) 0.38
Total Debt to Equity 0.16
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.91 $
Revenues (TTM) -
Cash Flow (TTM) 1.13 $
Cash 1.41 $
Book Value 1.14 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,324,063
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.